StockData

IRulya Therapeutics Inc. (IRLA) stock

IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30
$40.59+2.14 (+5.57%)

Close on Nov 18, 2026Market cap $41.28MP/E –Yield –

IRulya Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

No profit margin figures for IRulya Therapeutics

IRulya Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More IRulya Therapeutics figures

See a number that looks wrong?